Market Research > Industries > Healthcare

Market Research: Nonprescription Drugs Canada 2006

Nonprescription Drugs Canada 2006

Published February 2007

View PDF brochure
View fact sheet

This study provides an in-depth analysis of Canada's nonprescription drug industry for 2006, including 25 product categories and profiles of 15 major and 20 minor over-the-counter drug manufacturers. The report provides information on sales and market share of leading brands and private-label products, advertising and promotional activity, retail distribution, regulatory activity, competition from alternative medicines, new product activity, and five-year forecasts. (Y228G)

Order Online or Order Print

ORDER ONLINE

 
You may submit an online request to subscribe to sections of this report, using a simple three-step process. After submitting your online request, you will then be contacted by a member of our global sales team to confirm the final price, and complete the transaction. Upon acceptance of your order, we will deliver the files in pdf format via email.

STEP 1 of 3

– Select the sections in which you are interested by clicking on the appropriate boxes:

FULL REPORT [US$ 22 500 (twenty two thousand five hundred US Dollars)]

INTRODUCTION [US$ 0]

  • Table 1-1 ACRONYMS USED IN THE REPORT

INDUSTRY ANALYSIS [US$ 4 500]

    OVERALL MARKET AND TRENDS [US$ 2 700]
    • Table 3-1 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY VALUE, 2005 AND 2006
    • Table 3-2 RATE OF GROWTH FOR NONPRESCRIPTION DRUG CATEGORIES, 2005 TO 2006
    • Table 3-3 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY RETAIL OUTLET, 2006
    • Table 3-4 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY RETAIL OUTLET, 2006
    • Table 3-5 MANUFACTURERS’ SALES OF PRIVATE-LABEL NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2006
    • Table 3-6 PRIVATE-LABEL SALES OF NONPRESCRIPTION DRUGS AS A PERCENTAGE OF CATEGORY SALES, 2006
    • Table 3-7 HISTORICAL MANUFACTURERS’ SALES AND GROWTH RATES IN THE NONPRESCRIPTION DRUG INDUSTRY BY PRODUCT CATEGORY, 2001 TO 2006
    • Table 3-8 HISTORICAL AND FORECAST GROWTH OF THE NONPRESCRIPTION DRUG INDUSTRY
    • Table 3-9 FORECAST MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2006 AND 2011
    • Table 3-10 FORECAST MANUFACTURERS’ SALES GROWTH OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2006 TO 2011
    COMPETITIVE MARKET STRUCTURE [US$ 2 700]
    • Table 3-11 TOP 10 SUPPLIERS OF NONPRESCRIPTION DRUGS IN CANADA, 2006
    • Table 3-12 PERCENTAGE OF TOTAL SALES FOR THE TOP 14 SUPPLIERS
    • Table 3-14 CORPORATE OPERATING RESULTS OF 11 MAJOR MARKETERS OF NONPRESCRIPTION DRUGS IN CANADA, 2000 AND 2005
    • Table 3-15 FORECAST MANUFACTURERS’ SALES FOR THE TOP 14 SUPPLIERS OF NONPRESCRIPTION DRUGS IN CANADA, 2006 TO 2011
    • Table 3-16 FORECAST MANUFACTURERS’ SALES FOR THE TOP 15 SUPPLIERS OF NONPRESCRIPTION DRUGS IN CANADA, RANKED BY RATE OF GROWTH, 2006 TO 2011
    • Table 3-13 MANUFACTURERS’ SALES OF THE LEADING NONPRESCRIPTION DRUG SUPPLIERS TO CANADA BY PRODUCT CLASS, 2006
    • Table 3-14 CORPORATE OPERATING RESULTS OF 11 MAJOR MARKETERS OF NONPRESCRIPTION DRUGS IN CANADA, 2000 AND 2005

PRODUCTS [US$ 6 750]

    OVERVIEW [US$ 1 700]
    • Figure 4A-1 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2006
    • Table 4A-1 MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2005 AND 2006
    COUGH AND COLD PREPARATIONS [US$ 1 700]
    • Table 4B-1 MANUFACTURERS’ SALES OF COUGH AND COLD PREPARATIONS BY PRODUCT CATEGORY, 2005 AND 2006
    • Figure 4B-1 MANUFACTURERS’ SALES OF COUGH AND COLD REMEDIES BY PRODUCT CATEGORY, 2006
    • Table 4B-2 FORECAST SALES OF COUGH AND COLD PREPARATIONS BY PRODUCT CATEGORY, 2006 AND 2011
      ALLERGY RELIEF PRODUCTS [US$ 350]
      • Table 4B-3 NEW ALLERGY RELIEF PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4B-4 MANUFACTURERS’ SALES OF ALLERGY RELIEF PRODUCTS BY BRAND, 2005 AND 2006
      • Table 4B-5 DISTRIBUTION OF ALLERGY RELIEF PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      COLD MEDICATIONS [US$ 425]
      • Table 4B-6 NEW COLD MEDICATIONS INTRODUCED IN 2005 AND 2006
      • Table 4B-7 MANUFACTURERS’ SALES OF COLD MEDICATIONS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4B 8 MANUFACTURERS’ SALES OF COLD MEDICATIONS BY COMPANY, 2006
      • Table 4B-9 DISTRIBUTION OF COLD MEDICATIONS BY RETAIL OUTLET, 2005 AND 2006
      COUGH SYRUPS [US$ 350]
      • Table 4B-10 NEW COUGH SYRUPS INTRODUCED IN 2005 AND 2006
      • Table 4B-11 MANUFACTURERS’ SALES OF COUGH SYRUPS BY BRAND, 2005 AND 2006
      • Table 4B-12 DISTRIBUTION OF COUGH SYRUPS BY RETAIL OUTLET, 2005 AND 2006
      LOZENGES AND DROPS [US$ 350]
      • Table 4B-13 NEW LOZENGES AND DROPS INTRODUCED IN 2005 AND 2006
      • Table 4B-14 MANUFACTURERS’ SALES OF LOZENGES AND DROPS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4B-15 DISTRIBUTION OF LOZENGES AND DROPS BY RETAIL OUTLET, 2005 AND 2006
      NASAL DECONGESTANTS [US$ 250]
      • Table 4B-16 NEW NASAL DECONGESTANTS INTRODUCED IN 2005 AND 2006
      • Table 4B-17 MANUFACTURERS’ SALES OF NASAL DECONGESTANTS BY BRAND, 2005 AND 2006
      • Table 4B-18 DISTRIBUTION OF NASAL DECONGESTANTS BY RETAIL OUTLET, 2005 AND 2006
      SINUS REMEDIES [US$ 250]
      • Table 4B-19 NEW SINUS REMEDIES INTRODUCED IN 2005 AND 2006
      • Table 4B-20 MANUFACTURERS’ SALES OF SINUS REMEDIES BY BRAND, 2005 AND 2006
      • Table 4B-21 DISTRIBUTION OF SINUS REMEDIES BY RETAIL OUTLET, 2005 AND 2006
    DIGESTIVE PRODUCTS [US$ 1 700]
    • Table 4C-1 MANUFACTURERS’ SALES OF DIGESTIVE PRODUCTS BY PRODUCT CATEGORY, 2005 AND 2006
    • Figure 4C-1 MANUFACTURERS’ SALES OF DIGESTIVE PRODUCTS BY PRODUCT CATEGORY, 2006
    • Table 4C-2 FORECAST SALES OF DIGESTIVE PRODUCTS BY PRODUCT CATEGORY, 2006 AND 2011
      ANTACIDS [US$ 600]
      • Table 4C-3 NEW ANTACIDS INTRODUCED IN 2005 AND 2006
      • Table 4C-4 MANUFACTURERS’ SALES OF ANTACIDS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4C 5 MANUFACTURERS’ SALES OF ANTACIDS BY COMPANY, 2006
      • Table 4C 6 DISTRIBUTION OF ANTACIDS BY RETAIL OUTLET, 2005 AND 2006
      ANTIDIARRHEALS [US$ 425]
      • Table 4C-7 MANUFACTURERS’ SALES OF ANTIDIARRHEALS BY BRAND AND COMPANY, 2005 AND 2006
      • Table 4C-8 DISTRIBUTION OF ANTIDIARRHEALS BY RETAIL OUTLET, 2005 AND 2006
      LAXATIVES [US$ 500]
      • Table 4C-9 MANUFACTURERS’ SALES OF LAXATIVES BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4C 10 MANUFACTURERS’ SALES OF LAXATIVES BY COMPANY, 2006
      • Table 4C-11 DISTRIBUTION OF LAXATIVES BY RETAIL OUTLET, 2005 AND 2006
      OTHER DIGESTIVE PRODUCTS [US$ 425]
      • Table 4C-12 NEW OTHER DIGESTIVE PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4C-13 MANUFACTURERS’ SALES OF OTHER DIGESTIVE PRODUCTS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4C-14 DISTRIBUTION OF OTHER DIGESTIVE PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
    INTERNAL ANALGESICS [US$ 675]
    • Table 4D-1 MANUFACTURERS’ SALES OF INTERNAL ANALGESICS BY PRODUCT CATEGORY, 2005 AND 2006
    • Table 4D-2 NEW INTERNAL ANALGESICS INTRODUCED IN 2005 AND 2006
    • Table 4D-3 MANUFACTURERS’ SALES OF INTERNAL ANALGESICS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
    • Table 4D 4 MANUFACTURERS’ SALES OF INTERNAL ANALGESICS BY COMPANY, 2006
    • Table 4D 5 DISTRIBUTION OF INTERNAL ANALGESICS BY RETAIL OUTLET, 2005 AND 2006
    NUTRITIONAL PRODUCTS [US$ 1 025]
    • Table 4E-1 MANUFACTURERS’ SALES NUTRITIONAL PRODUCTS BY PRODUCT CATEGORY, 2005 AND 2006
    • Figure 4E-1 MANUFACTURERS’ SALES OF NUTRITIONALS BY PRODUCT CATEGORY, 2006
    • Table 4E-2 FORECAST SALES OF NUTRITIONAL PRODUCTS BY PRODUCT CATEGORY, 2006 AND 2011
      DIET AIDS [US$ 300]
      • Table 4E-3 NEW DIET AIDS INTRODUCED IN 2005 AND 2006
      • Table 4E-4 MANUFACTURERS’ SALES OF DIET AIDS BY BRAND, 2005 AND 2006
      • Table 4E-5 DISTRIBUTION OF DIET AIDS BY RETAIL OUTLET, 2005 AND 2006
      HERBAL PRODUCTS [US$ 400]
      • Table 4E-6 NEW HERBAL PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4E-7 COMMON HERBAL PRODUCTS AND TYPICAL USES
      • Table 4E-8 MANUFACTURERS’ SALES OF HERBAL PRODUCTS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4E-9 PRIVATE-LABEL SALES OF HERBAL PRODUCTS BY PRODUCT SEGMENT, 2005 AND 2006
      • Table 4E-10 DISTRIBUTION OF HERBAL PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      VITAMINS AND MINERALS [US$ 400]
      • Table 4E-11 NEW VITAMINS AND MINERALS INTRODUCED IN 2005 AND 2006
      • Table 4E-12 MANUFACTURERS’ SALES OF VITAMINS AND MINERALS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4E-13 MANUFACTURERS’ SALES OF VITAMINS AND MINERALS BY PRODUCT SEGMENT, 2005 AND 2006
      • Table 4E-14 DISTRIBUTION OF VITAMINS AND MINERALS BY RETAIL OUTLET, 2005 AND 2006
    TOPICAL PRODUCTS [US$ 1 700]
    • Table 4F 1 MANUFACTURERS’ SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY, 2005 AND 2006
    • Figure 4F-1 MANUFACTURERS’ SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY, 2006
    • Table 4F-2 FORECAST SALES OF TOPICAL PRODUCTS BY PRODUCT CATEGORY, 2006 AND 2011
      ACNE AIDS [US$ 250]
      • Table 4F-3 NEW ACNE AIDS INTRODUCED IN 2005 AND 2006
      • Table 4F-4 MANUFACTURERS’ SALES OF ACNE AIDS BY BRAND, 2005 AND 2006
      • Table 4F-5 DISTRIBUTION OF ACNE AIDS BY RETAIL OUTLET, 2005 AND 2006
      CONTACT LENS SOLUTIONS [US$ 250]
      • Table 4F-6 NEW CONTACT LENS SOLUTIONS INTRODUCED IN 2005 AND 2006
      • Table 4F-7 MANUFACTURERS’ SALES OF CONTACT LENS SOLUTIONS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4F 8 MANUFACTURERS’ SALES OF CONTACT LENS SOLUTIONS BY COMPANY, 2006
      • Table 4F-9 DISTRIBUTION OF CONTACT LENS SOLUTIONS BY RETAIL OUTLET, 2005 AND 2006
      DIAPER RASH PRODUCTS [US$ 175]
      • Table 4F-10 MANUFACTURERS’ SALES OF DIAPER RASH PRODUCTS BY BRAND, 2005 AND 2006
      • Table 4F-11 DISTRIBUTION OF DIAPER RASH PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      EYE CARE PRODUCTS [US$ 250]
      • Table 4F-12 NEW EYE CARE PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4F-13 MANUFACTURERS’ SALES OF EYE CARE PRODUCTS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4F 14 MANUFACTURERS’ SALES OF EYE CARE PRODUCTS BY COMPANY, 2006
      • Table 4F-15 DISTRIBUTION OF EYE CARE PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      FEMININE YEAST INFECTION REMEDIES [US$ 250]
      • Table 4F-16 MANUFACTURERS’ SALES OF FEMININE YEAST INFECTION REMEDIES BY BRAND, 2005 AND 2006
      • Table 4F-17 DISTRIBUTION OF FEMININE YEAST INFECTION REMEDIES BY RETAIL OUTLET, 2005 AND 2006
      FIRST AID PRODUCTS [US$ 250]
      • Table 4F-18 NEW FIRST AID PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4F 19 MANUFACTURERS’ SALES OF FIRST AID PRODUCTS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4F 20 MANUFACTURERS’ SALES OF FIRST AID PRODUCTS BY COMPANY, 2006
      • Table 4F-21 DISTRIBUTION OF FIRST AID PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      FOOT CARE PRODUCTS [US$ 250]
      • Table 4F-22 NEW FOOT CARE PRODUCTS INTRODUCED IN 2005 AND 2006
      • Table 4F 23 MANUFACTURERS’ SALES OF FOOT CARE PRODUCTS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4F 24 MANUFACTURERS’ SALES OF FOOT CARE PRODUCTS BY COMPANY, 2006
      • Table 4F-25 DISTRIBUTION OF FOOT CARE PRODUCTS BY RETAIL OUTLET, 2005 AND 2006
      HEMORRHOIDAL PREPARATIONS [US$ 175]
      • Table 4F-26 MANUFACTURERS’ SALES OF HEMORRHOIDAL PREPARATIONS BY BRAND, 2005 AND 2006
      • Table 4F-27 DISTRIBUTION OF HEMORRHOIDAL PREPARATIONS BY RETAIL OUTLET, 2005 AND 2006
      TOPICAL ANALGESICS [US$ 175]
      • Table 4F-28 NEW TOPICAL ANALGESICS INTRODUCED IN 2005 AND 2006
      • Table 4F 29 MANUFACTURERS’ SALES OF TOPICAL ANALGESICS BY BRAND, 2005 AND 2006
      • Table 4F-30 DISTRIBUTION OF TOPICAL ANALGESICS BY RETAIL OUTLET, 2005 AND 2006
    MISCELLANEOUS PRODUCTS [US$ 1 025]
    • Table 4G-1 MANUFACTURERS’ SALES OF MISCELLANEOUS PRODUCTS BY PRODUCT CATEGORY, 2005 AND 2006
    • Figure 4G-1 MANUFACTURERS’ SALES OF MISCELLANEOUS PRODUCTS BY PRODUCT CATEGORY, 2006
    • Table 4G-2 FORECAST SALES OF MISCELLANEOUS PRODUCTS BY PRODUCT CATEGORY, 2006 AND 2011
      HOME DIAGNOSTIC TEST KITS [US$ 525]
      • Table 4G-3 NEW HOME DIAGNOSTIC TEST KITS INTRODUCED IN 2005 AND 2006
      • Table 4G-4 MANUFACTURERS’ SALES OF HOME DIAGNOSTIC TEST KITS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4G-5 DISTRIBUTION OF HOME DIAGNOSTIC TEST KITS BY RETAIL OUTLET, 2005 AND 2006
      SLEEPING AIDS [US$ 250]
      • Table 4G-6 NEW SLEEPING AIDS INTRODUCED IN 2005 AND 2006
      • Table 4G-7 MANUFACTURERS’ SALES OF SLEEPING AIDS BY BRAND, 2005 AND 2006
      • Table 4G-8 DISTRIBUTION OF SLEEPING AIDS BY RETAIL OUTLET, 2005 AND 2006
      SMOKING CESSATION AIDS [US$ 350]
      • Table 4G-9 MANUFACTURERS’ SALES OF SMOKING CESSATION AIDS BY PRODUCT SEGMENT AND BRAND, 2005 AND 2006
      • Table 4G-10 DISTRIBUTION OF SMOKING CESSATION AIDS BY RETAIL OUTLET, 2005 AND 2006

MAJOR COMPANIES [US$ 6 750]

  • Table 5-1 LEADING MANUFACTURERS’ SALES OF NONPRESCRIPTION DRUGS BY COMPANY, 2006
    ABBOTT LABORATORIES [US$ 350]
    • Table 5-2 ABBOTT LABORATORIES’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-3 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF ABBOTT LABORATORIES BY CATEGORY, 2005 TO 2011
    BAUSCH & LOMB [US$ 350]
    • Table 5-4 BAUSCH & LOMB’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-5 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF BAUSCH & LOMB BY CATEGORY, 2006 TO 2011
    BAYER GROUP [US$ 1 025]
    • Table 5-6 BAYER GROUP’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-7 NEW PRODUCTS LAUNCHED BY BAYER GROUP, 2005 AND 2006
    • Table 5-8 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF BAYER GROUP BY CATEGORY, 2006 TO 2011
    CHURCH & DWIGHT [US$ 675]
    • Table 5-9 CHURCH & DWIGHT’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-10 NEW PRODUCTS LAUNCHED BY CHURCH & DWIGHT, 2005 AND 2006
    • Table 5-11 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF CHURCH & DWIGHT BY CATEGORY, 2006 TO 2011
    GLAXOSMITHKLINE [US$ 1 025]
    • Table 5-12 GLAXOSMITHKLINE’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-13 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF GLAXOSMITHKLINE BY CATEGORY, 2006 TO 2011
    JAMIESON LABORATORIES [US$ 350]
    • Table 5-14 JAMIESON LABORATORIES’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-15 NEW PRODUCTS LAUNCHED BY JAMIESON LABORATORIES, 2005 AND 2006
    • Table 5-16 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF JAMIESON LABORATORIES BY CATEGORY, 2006 TO 2011
    JOHNSON & JOHNSON [US$ 1 025]
    • Table 5-17 JOHNSON & JOHNSON’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-18 NEW PRODUCTS LAUNCHED BY JOHNSON & JOHNSON, 2005 AND 2006
    • Table 5-19 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF JOHNSON & JOHNSON BY CATEGORY, 2006 TO 2011
    JOHNSON & JOHNSON-MERCK CONSUMER PHARMACEUTICALS COMPANY
    [US$ 350]
    • Table 5-20 JOHNSON & JOHNSON–MERCK’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-21 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF JOHNSON & JOHNSON–MERCK BY CATEGORY, 2006 TO 2011
    NOVARTIS [US$ 1 025]
    • Table 5-22 NOVARTIS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-23 NEW PRODUCTS LAUNCHED BY NOVARTIS, 2005 AND 2006
    • Table 5-24 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF NOVARTIS BY CATEGORY, 2006 TO 2011
    PERRIGO [US$ 675]
    • Table 5-25 PERRIGO’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY, 2005 AND 2006
    • Table 5-26 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF PERRIGO BY CATEGORY, 2006 TO 2011
    PROCTER & GAMBLE [US$ 350]
    • Table 5-27 PROCTER & GAMBLE’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-28 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF PROCTER & GAMBLE BY CATEGORY, 2006 TO 2011
    ROCHE HOLDINGS LTD. [US$ 350]
    • Table 5-29 ROCHE HOLDINGS’ SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-30 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF ROCHE HOLDINGS BY CATEGORY, 2006 TO 2011
    SCHERING-PLOUGH [US$ 675]
    • Table 5-31 SCHERING-PLOUGH’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-32 NEW PRODUCTS LAUNCHED BY SCHERING-PLOUGH, 2005 AND 2006
    • Table 5-33 FORECAST GROWTH FOR NONPRESCRIPTION DRUGS OF SCHERING-PLOUGH BY CATEGORY, 2006 TO 2011
    WYETH [US$ 675]
    • Table 5-34 WYETH’S SALES OF NONPRESCRIPTION DRUGS BY PRODUCT CATEGORY AND BRAND, 2005 AND 2006
    • Table 5-35 NEW PRODUCTS LAUNCHED BY WYETH, 2005 AND 2006
    • Table 5-36 FORECAST GROWTH FOR WYETH’S NONPRESCRIPTION DRUGS BY CATEGORY, 2006 TO 2011

MINOR COMPANIES [US$ 4 500]

  • Table 6-1 ESTIMATED SALES OF NONPRESCRIPTION DRUGS OF 31 MINOR MANUFACTURERS, 2005 AND 2006
    ALCON (NESTLE) [US$ 50]
    ADVANCED MEDICAL OPTICS (ALLERGAN) [US$ 50]
    CADBURY SCHWEPPES [US$ 50]
    CHATTEM [US$ 50]
    COMBE, INC. [US$ 50]
    CONTRACT PHARMACEUTICALS LTD. [US$ 50]
    CV THECNOLOGIES [US$ 50]
    HOLISTA HEALTH [US$ 50]
    MEAD JOHNSON NUTRITIONALS/BRISTOL-MYERS SQUIBB [US$ 50]
    PENDOPHARM [US$ 50]
    PRESTIGE BRANDS INTERNATIONAL [US$ 50]
    PERDUE PHARMA [US$ 50]
    RECKITT BENCKISER [US$ 50]
    RICOLA [US$ 50]
    SANOFI-AVENTIS [US$ 50]
    STIEFEL LABORATORIES [US$ 50]
    SWISS HERBAL REMEDIES [US$ 50]
    TFB ASSOCIATES [US$ 50]
    WN PHARMACEUTICALS [US$ 50]

MARKET WATCH BULLETIN [US$ 4 500]

    COMPANY DEVELOPMENTS [US$ 1 800]
    REGULATORY UPDATE [US$ 1 800]
    • Table 7-1 NONPRESCRIPTION DRUG INGREDIENTS AND THEIR SCHEDULES
    • Table 7-2 RX-TO-OTC SWITCHES IN CANADA, 1985 TO 2006
    NEW PRODUCTS [US$ 1 350]
    • Table 7-3 NEW PRODUCT INTRODUCTIONS IN CANADA FOR 2005 AND 2006, SORTED BY CATEGORY
    • Table 7-4 NEW PRODUCT INTRODUCTIONS IN CANADA FOR 2005 AND 2006, SORTED BY COMPANY

STEP 2 of 3

– Provide your contact information:

All fields in *BOLD are required.

*Name:
*Title:
*Company/Division:
*Address 1 :
  Address 2 :
*City:
*State/Province:
*Zip/Postal code:
*Country:
*Phone:
  Fax:
*Email:

STEP 3 of 3

– Review and accept our subscription terms and conditions by viewing and clicking below:

*Please view our terms and conditions, and check this box to indicate your acceptance of these terms and conditions.

Thank you for your interest in subscribing to our syndicated reports. To complete this process, please click on the button below and a member of our global sales team will contact you shortly to confirm the final price and complete the transaction. Upon acceptance of your order, we will deliver the files in PDF format via email.

 

Market Research
Overview
Industry Practices
Purchasing a Report
 
Report Catalogs
Full Reports Catalog >>
The People of Kline
Kline Team Bios
Upcoming Appearances
Our Philosophy
 
Client Success
View all Client Successes >>
 
Contact Us
Send a Consulting RFP
Purchase a Research Report
Request a Meeting
General Inquiries

Questions?

Call or Email Us